ADIAL PHARMACEUTICALS, INC. (ADIL) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	S-1	S-1/A
ASSETS
Cash and cash equivalents	6.1	4.4	6.8	3.9	0.0	87,993.0
Prepaid expenses and other current assets	0.4	0.5	0.4	0.3	0.0	20,553.0
Total Current Assets	6.5	5.1	7.7	4.7	0.0	141,413.0
Total Assets	7.5	5.5	7.7	4.7	0.0	151,526.0

LIABILITIES AND STOCKHOLDERS’ EQUITY
Accounts payable	0.3	0.6	0.2	0.1
Accrued expenses	2.4	0.9	0.3	0.2
Accrued expenses, related party	2.4	0.9	0.3	0.2
Other current liabilities	0.0
Total Current Liabilities	2.7	1.5	0.5	0.3	1.0	255,019.0
Deferred tax liability	0.0
Total Liabilities	4.0	1.5

Commitments and contingencies – see Note 10
Stockholders’ Equity
Preferred Stock, 5,000,000 shares authorized with a par value of $0.001 per share, 0 shares outstanding at June 30, 2023 and December 31, 2022
Common Stock	0.0	0.0	0.0	0.0	0.0	3,261.0
Additional paid in capital	54.4	35.5	27.8	16.5	-0.6	9,831,491.0
Accumulated deficit	-50.9	-31.5	-20.6	-12.0	-0.4	-9,938,245.0
Total Stockholders’ Equity	3.5	4.0	7.1	4.4	-1.0	-103,493.0
Total Liabilities and Stockholders’ Equity	7.5	5.5	7.7	4.7	0.0	151,526.0